TD Asset Management
OPTR

TD Asset Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

TD Asset Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-51,200
Closed -$645K – 1342
2013
Q3 		$645K Sell
51,200
-34,200
-40% -$453K ﹤0.01% 931
2013
Q2 		$1.24M Buy
+85,400
New +$1.24M ﹤0.01% 821

TD Asset Management's OPTR Position: Q4 2013 in Review

TD Asset Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 51,200 shares — an estimated $645K sold.

TD Asset Management first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.24M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • TD Asset Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • TD Asset Management sold 51,200 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $645K.
  • TD Asset Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • TD Asset Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.24M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on TD Asset Management's 13F filing for Q4 2013, filed 7 Feb 2014.